Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Observational × Tamoxifen × Clear all

Status

Sponsor Class

OTHER 17 OTHER_GOV 1 NIH 1 INDUSTRY 1

Study Type

Interventional 42 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Amplified Fragment Length Polymorphism Analysis 17 Gene Expression Profiling 13 Microarray Analysis 11 Immunohistochemistry 10 Polymerase Chain Reaction 8 Specimen Handling 6 Psychiatric Rehabilitation 6 Reverse Transcriptase Polymerase Chain Reaction 5 Mass Spectrometry 4 Biopsy 4 Genetic Linkage 3 Flow Cytometry 3 DNA Methylation 3 Cytogenetic Analysis 3 Chromatography, High Pressure Liquid 3 Watchful Waiting 2 Therapeutics 2 Molecular Diagnostic Techniques 2 Mental Status and Dementia Tests 2 Leukapheresis 2 Immunologic Techniques 2 Bleeding Time 2 hepatitis B hyperimmune globulin 1 gallium Ga 68 dotatate 1 etoposide phosphate 1 adefovir dipivoxil 1 Tissue Banks 1 Tamoxifen 1 Surgical Procedures, Operative 1 Spectroscopy, Fourier Transform Infrared 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00228930 2008-09-25

Tamoxifen Pharmacogenetics and Clinical Effects

National Institute of General Medical Sciences (NIGMS)

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡